<< Read Full Article

InterMune Up Despite So-So Hep C Data

Stock quotes in this article: ITMN , VRTX , SGP , JNJ  

Updated from 10:39 a.m. EST

SAN FRANCISCO -- InterMune(ITMN Quote) has moved forward with development of a new hepatitis C drug, dubbed ITMN-191, on the premise that it will be more potent and more convenient to administer than a similar drug from Vertex Pharmaceuticals(VRTX Quote).

But new data released Monday morning on ITMN-191 doesn't completely live up to that billing.

A 600 mg dose of ITMN-191 given twice daily and combined with the current standard of care therapy for hepatitis C reduced the amount of virus below detectable levels in 13% of patients treated for 14 days. ...

<< Read Full Article

Recent Comments

Loading .....




Dow Jones S&P 500 NASDAQ 10-Year Note
10,452.00 1,107.93 2,201.05 36.03
Oil *
72.08
DOWN
49.05
DOWN
6.18
DOWN
11.05
UP
0.57
10 Yr
3.60%
SPDR Gold
110.21
-0.47%
-0.55%
-0.50%
+1.61%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services